{
    "organizations": [],
    "uuid": "6c2365beebf2896351b3a9ba079c01aee1de77d7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-momenta-pharmaceuticals-planning-f/brief-momenta-pharmaceuticals-planning-for-glatopa-40-mg-launch-in-2h-2018-however-idUSFWN1P30Q3",
    "ord_in_thread": 0,
    "title": "BRIEF-Momenta Pharmaceuticals Planning For Glatopa 40 Mg Launch In 2H 2018 However",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Momenta Pharmaceuticals Inc:\n* MOMENTA PHARMACEUTICALS - CO PLANNING FOR GLATOPA 40 MG LAUNCH IN 2H 2018; HOWEVER, POTENTIAL REMAINS FOR 1H 2018 LAUNCH - SEC FILING Source text:( bit.ly/2CTkx5R ) Further company coverage:\n ",
    "published": "2018-01-08T21:25:00.000+02:00",
    "crawled": "2018-01-09T17:12:58.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "momentum",
        "pharmaceutical",
        "inc",
        "momentum",
        "pharmaceutical",
        "co",
        "planning",
        "glatopa",
        "mg",
        "launch",
        "2h",
        "however",
        "potential",
        "remains",
        "1h",
        "launch",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}